Default company panoramic image
20a86da2 fbcd 4620 ab39 9d21b5bd3e43


A medical device company, developing a revolutionary optical instrument capable of rapid, very accurate, non-invasive skin cancer diagnosis.

  • Stage Product In Development
  • Industry Medical Devices and Equipment
  • Location Fresno, CA, USA
  • Currency USD
  • Website

Company Summary

The company’s product, the DDx, is a hand-held fiber-optic diagnostic probe that uses Multi-Modal Spectroscopy (MMS: diffuse reflectance, intrinsic fluorescence, and Raman spectroscopies), to capture and analyze unique spectral signatures of suspicious skin lesions. DermDx has completed proof of concept clinical studies on live patients and demonstrated 100% sensitivity for detecting all skin cancers and a 42-75% reduction in unneeded biopsies.


  • Default avatar
    Sampath Srikanth

    Dr. Sampath Srikanth, PhD, MBA, Founder and CEO. Over 10 years’ relevant experience in business development, product management and general management at IDEXX Laboratories, Inc. (IDXX).

  • Default avatar
    Usha Nagavarapu
    VP, Product Development

    Dr. Usha Nagavarapu, PhD, Founder and VP of Product Development. Over 10 years’ of experience in research, product development, marketing, and business development. Expertise in oncology including skin cancer, Prinicpal, Bioconsulting providing preclinical services to bio-pharma companies. Formerly led Oncology programs at AGY Therapeutics, MMRI, and has post-doctoral training at Stanford Med School in Dermatology.

  • Default avatar
    Robert Hulsy

    Mr. Robert S. Hulsy, MBA, Founder and Chairman. Mr. Hulsy has extensive, highly relevant experience in diagnostic instrumentation, operations, and new product launch with Corning Abbot Laboratories, and American Environmental Network. One of 3 business unit managers at IDEXX until 2008 when he founded Granite Point Group.

  • Default avatar
    William Riggs
    VP, TEchnical Operations

    Dr. William Riggs, PhD, Founder and VP of Technical Operations. Founding CEO of River Diagnostics, a leader in in vivo optical analysis of biological tissue. Formerly held executive roles in technology development at DuPont and Perkin-Elmer. Held faculty positions at MIT and Georgia Tech in technology and innovation management.